Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Doses in TAP Block for Abdominal Cancer Surgery
NCT06624319Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Total morphine consumption at 24 hours. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06624319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06624319.